Liquidia inks $100M financing agreement amid patent dispute


The pharmaceutical company has landed financing to support the potential launch of a drug at the center of an ongoing patent dispute with United Therapeutics.

Previous Amid nationwide home sales decline, Houston again tops master-planned communities lists
Next Another large multifamily project could be coming to west Wichita's edge